Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.

× No keyword cloud information.

37 in total

Review 1. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors: L A Pagliaro; L Z Benet
Journal: J Pharmacokinet Biopharm Date: 1975-10

2. Clinical pharmacokinetics of beta-adrenoreceptors blockers.

Authors: G Johnsson; C G Regårdh
Journal: Drugs Date: 1976 Impact factor: 9.546

3. Problems in assessing beta-adrenoceptor antagonism in man.

Authors: C F George
Journal: Br J Clin Pharmacol Date: 1975-02 Impact factor: 4.335

Review 4. Hypertension: which beta-blocker?

Authors: H J Waal-Manning
Journal: Drugs Date: 1976-12 Impact factor: 9.546

5. Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.

Authors: J M Bell; C J Russell; J K Nelson; J G Kelly; D G McDevitt
Journal: Br J Clin Pharmacol Date: 1977-02 Impact factor: 4.335

6. The elimination of practolol by two human subjects.

Authors: L G Dring; A Gorchein; A A Mahgoub; R L Smith
Journal: Br J Clin Pharmacol Date: 1978-03 Impact factor: 4.335

7. Bioavailability of beta-adrenoceptor blocking drugs.

Authors: G Johnsson; C G Regardh
Journal: Br J Clin Pharmacol Date: 1976-12 Impact factor: 4.335

8. Drugs in the elderly.

Authors: J R Trounce
Journal: Br J Clin Pharmacol Date: 1975-08 Impact factor: 4.335

Review 9. Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors: B N Singh; W R Thoden; A Ward
Journal: Drugs Date: 1985-06 Impact factor: 9.546

10. The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.

Authors: T B Tjandramaga; R Verbeeck; J Thomas; R Verbesselt; R Verberckmoes; P J Schepper
Journal: Br J Clin Pharmacol Date: 1976-04 Impact factor: 4.335